Marc Rubin M.D.
Net Worth

Last updated:

What is Marc Rubin M.D. net worth?

The estimated net worth of Dr. Marc Rubin M.D. is at least $7,073,804 as of 21 Sep 2018. He owns shares worth $2,814,964 as insider and has received compensation worth at least $4,258,840 in Titan Pharmaceuticals, Inc..

What is the salary of Marc Rubin M.D.?

Dr. Marc Rubin M.D. salary is $250,520 per year as Executive Chairman & Principal Executive Officer in Titan Pharmaceuticals, Inc..

How old is Marc Rubin M.D.?

Dr. Marc Rubin M.D. is 70 years old, born in 1955.

What stocks does Marc Rubin M.D. currently own?

As insider, Dr. Marc Rubin M.D. owns shares in one company:

Company Title Shares Price per share Total value
Titan Pharmaceuticals, Inc. (TTNP) Executive Chairman & Principal Executive Officer 556,317 $5.06 $2,814,964

What does Titan Pharmaceuticals, Inc. do?

Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in Canada and the European Union. It is also developing kappa opioid agonist peptide program (TP-2021) for use in combination with ProNeura technology for the treatment of chronic pruritus; nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.

TTNP logo
TTNP
Titan Pharmaceuticals, Inc.
$5.06

Marc Rubin M.D. insider trading

Titan Pharmaceuticals, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 400,000 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 50,000 N/A N/A
Purchase
Common Stock 100,000 N/A N/A
Purchase
Common Stock, $0.001 par value per share 50,000 N/A N/A
Purchase
Common Stock, $0.001 par value per share 38,400 N/A N/A
Purchase
Common Stock 5,000 N/A N/A
Purchase
Common Stock 15,000 N/A N/A
Purchase
Common Stock 10,000 N/A N/A

Titan Pharmaceuticals key executives

Titan Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Katherine L. Beebe-DeVarney Ph.D. (64) Pres, Chief Operating Officer & Director
  • Dr. Marc Rubin M.D. (70) Executive Chairman & Principal Executive Officer